These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Period of remission after treatment with UVA-1 in sclerodermic skin diseases. Kroft EB, van de Kerkhof PC, Gerritsen MJ, de Jong EM. J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):839-44. PubMed ID: 18452527 [Abstract] [Full Text] [Related]
4. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis. Rose RF, Turner D, Goodfield MJ, Goulden V. Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995 [Abstract] [Full Text] [Related]
6. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study. Andres C, Kollmar A, Mempel M, Hein R, Ring J, Eberlein B. Br J Dermatol; 2010 Feb 01; 162(2):445-7. PubMed ID: 19785603 [Abstract] [Full Text] [Related]
15. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. Kreuter A, Hyun J, Stücker M, Sommer A, Altmeyer P, Gambichler T. J Am Acad Dermatol; 2006 Mar 01; 54(3):440-7. PubMed ID: 16488295 [Abstract] [Full Text] [Related]
16. Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study. Shalaby SM, Bosseila M, Fawzy MM, Abdel Halim DM, Sayed SS, Allam RS. Lasers Med Sci; 2016 Nov 01; 31(8):1707-1715. PubMed ID: 27510285 [Abstract] [Full Text] [Related]